Council for Scientific and Industrial Research (CSIR) has launched BGR-34 – an anti-diabetic ayurvedic drug designed for type 2 Diabetes mellitus. BGR-34 is developed jointly by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP), the research units of CSIR at Lucknow. BGR-34 has been economically priced at Rs. 5 per tablet as compared to latest DPP4 inhibitors globally.

A K S Rawat, Sr Principal Scientist of CSIR-NBRI said six crore of the adult Indian population had been found to be diabetic and there is no effective solution for diabetes as yet. He said CSIR’s premier research institutions have developed and established the efficacy of BGR-34.

The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs, he added. The scientists of NBRI and CIMAP joined hands in developing the drug and they had in-depth study of over 500 renowned ancient herbs and finally identified the six best herbs listed in Ayurvedic ancient texts to develop an anti-diabetic formulation.

Daya Nandan Mani, Senior Scientist of CSIR-NBRI, said Pre-clinical studies of this anti-diabetic formulation revealed significant reduction in high blood sugar level in diabetes induced experimental subjects.